Director Hausman buys 5,500 shares in 2 transactions at $3.60–$3.62 as 4 other insiders buy within 14 days; IMRX at 52-week high.
Diana Hausman, a director at Immuneering Corp, purchased 5,500 shares across 2 transactions on 2025-07-02 at blended average price of $3.61. The stock is currently at $4.05, matching its 52-week high, and has rallied +90.1% over 30 days and +224.0% over 90 days. This purchase occurs within a broader cluster pattern: 4 other insiders also bought within the past 14 days, suggesting coordinated conviction at current valuations. However, Immuneering remains unprofitable with net income of -$15,046,132.00 and zero revenue in the latest quarter, with annual revenue growth of -100.0%, so the recent price appreciation appears disconnected from fundamental improvement. The convergence of multiple insider purchases at elevated price levels warrants scrutiny of whether this reflects genuine business momentum or other factors driving insider capital deployment.